{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:00:11Z","timestamp":1787166011722,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500546"],"award-info":[{"award-number":["81500546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-0866-9","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:39:20Z","timestamp":1522795160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study"],"prefix":"10.1186","volume":"19","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongman","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"issue":"6 Suppl","key":"866_CR1","doi-asserted-by":"publisher","first-page":"25S","DOI":"10.1016\/j.amjcard.2012.06.013","volume":"110","author":"A Vonk-Noordegraaf","year":"2012","unstructured":"Vonk-Noordegraaf A, Souza R. Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension? Am J Cardiol. 2012;110(6 Suppl):25S\u201331S.","journal-title":"Am J Cardiol"},{"issue":"6","key":"866_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/CRD.0000000000000035","volume":"22","author":"M Sharma","year":"2014","unstructured":"Sharma M, Pinnamaneni S, Aronow WS, Jozwik B, Frishman WH. Existing drugs and agents under investigation for pulmonary arterial hypertension. Cardiol Rev. 2014;22(6):297\u2013305.","journal-title":"Cardiol Rev"},{"issue":"4","key":"866_CR3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1053\/j.ajkd.2012.07.029","volume":"61","author":"D Bolignano","year":"2013","unstructured":"Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, Wiecek A, Martinez-Castelao A, Covic A, Goldsmith D, et al. Pulmonary hypertension in CKD. Am J Kidney Dis. 2013;61(4):612\u201322.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"866_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cardfail.2011.03.003","volume":"17","author":"F Haddad","year":"2011","unstructured":"Haddad F, Fuh E, Peterson T, Skhiri M, Kudelko KT, De Jesus PV, Winkelmayer WC, Doyle RL, Chertow GM, Zamanian RT. Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure. J Card Fail. 2011;17(7):533\u20139.","journal-title":"J Card Fail"},{"issue":"7","key":"866_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685\u2013713. 786-788","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"866_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0735-1097(85)80172-8","volume":"6","author":"M Berger","year":"1985","unstructured":"Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6(2):359\u201365.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"866_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1159\/000104443","volume":"30","author":"M Buemi","year":"2007","unstructured":"Buemi M, Senatore M, Gallo GC, Crasci E, Campo S, Sturiale A, Coppolino G, Bolignano D, Frisina N. Pulmonary hypertension and erythropoietin. Kidney Blood Press Res. 2007;30(4):248\u201352.","journal-title":"Kidney Blood Press Res"},{"issue":"23","key":"866_CR8","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1161\/hc4801.100076","volume":"104","author":"BM McQuillan","year":"2001","unstructured":"McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation. 2001;104(23):2797\u2013802.","journal-title":"Circulation"},{"issue":"2","key":"866_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0733-8651(18)30368-0","volume":"8","author":"NB Schiller","year":"1990","unstructured":"Schiller NB. Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography. Cardiol Clin. 1990;8(2):277\u201387.","journal-title":"Cardiol Clin"},{"issue":"4","key":"866_CR10","doi-asserted-by":"publisher","first-page":"A31","DOI":"10.12659\/MSM.882607","volume":"18","author":"R Patel","year":"2012","unstructured":"Patel R, Aronow WS, Patel L, Gandhi K, Desai H, Kaul D, Sahgal SP. Treatment of pulmonary hypertension. Med Sci Monit. 2012;18(4):A31\u20139.","journal-title":"Med Sci Monit"},{"issue":"16","key":"866_CR11","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.01.024","volume":"51","author":"KM Chin","year":"2008","unstructured":"Chin KM, Rubin LJ. Pulmonary arterial hypertension. J Am Coll Cardiol. 2008;51(16):1527\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"866_CR12","doi-asserted-by":"publisher","first-page":"e114392","DOI":"10.1371\/journal.pone.0114392","volume":"9","author":"Z Li","year":"2014","unstructured":"Li Z, Liang X, Liu S, Ye Z, Chen Y, Wang W, Li R, Xu L, Feng Z, Shi W. Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS One. 2014;9(12):e114392.","journal-title":"PLoS One"},{"key":"866_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ypmed.2016.12.016","volume":"97","author":"D Walther","year":"2017","unstructured":"Walther D, Curjuric I, Dratva J, Schaffner E, Quinto C, Schmidt-Trucksass A, Eze IC, Burdet L, Pons M, Gerbase MW, et al. Hypertension, diabetes and lifestyle in the long-term - results from a Swiss population-based cohort. Prev Med. 2017;97:56\u201361.","journal-title":"Prev Med"},{"key":"866_CR14","doi-asserted-by":"crossref","unstructured":"Brida M, Dimopoulos K, Kempny A, Liodakis E, Alonso-Gonzalez R, Swan L, Uebing A, Baumgartner H, Gatzoulis MA, Diller GP. Body mass index in adult congenital heart disease. Heart. 2017;103(16):1250\u20131257.","DOI":"10.1136\/heartjnl-2016-310571"},{"issue":"Suppl 4","key":"866_CR15","doi-asserted-by":"publisher","first-page":"v130","DOI":"10.1093\/ndt\/gft072","volume":"28","author":"E Cohen","year":"2013","unstructured":"Cohen E, Fraser A, Goldberg E, Milo G, Garty M, Krause I. Association between the body mass index and chronic kidney disease in men and women. A population-based study from Israel. Nephrol Dial Transplant. 2013;28(Suppl 4):v130\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"866_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fped.2015.00071","volume":"3","author":"RL van Loon","year":"2015","unstructured":"van Loon RL, Bartelds B, Wagener FA, Affara N, Mohaupt S, Wijnberg H, Pennings SW, Takens J, Berger RM. Erythropoietin attenuates pulmonary vascular remodeling in experimental pulmonary arterial hypertension through interplay between endothelial progenitor cells and Heme oxygenase. Front Pediatr. 2015;3:71.","journal-title":"Front Pediatr"},{"issue":"20","key":"866_CR17","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.115.019351","volume":"133","author":"EL Brittain","year":"2016","unstructured":"Brittain EL, Talati M, Fessel JP, Zhu H, Penner N, Calcutt MW, West JD, Funke M, Lewis GD, Gerszten RE, et al. Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension. Circulation. 2016;133(20):1936\u201344.","journal-title":"Circulation"},{"key":"866_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1874306400903010053","volume":"3","author":"S Ulrich","year":"2009","unstructured":"Ulrich S, Hersberger M, Fischler M, Huber LC, Senn O, Treder U, Speich R, Schmid C. Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension. Open Respir Med J. 2009;3:53\u201360.","journal-title":"Open Respir Med J"},{"issue":"5","key":"866_CR19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","volume":"7","author":"SG Wannamethee","year":"2014","unstructured":"Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail. 2014;7(5):732\u20139.","journal-title":"Circ Heart Fail"},{"issue":"2","key":"866_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11255-014-0889-5","volume":"47","author":"G Genctoy","year":"2015","unstructured":"Genctoy G, Arikan S, Gedik O. Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria. Int Urol Nephrol. 2015;47(2):353\u20138.","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"866_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrneph.2013.44","volume":"9","author":"MG Betjes","year":"2013","unstructured":"Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013;9(5):255\u201365.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"866_CR22","doi-asserted-by":"publisher","first-page":"e121750","DOI":"10.1371\/journal.pone.0121750","volume":"10","author":"E Schepers","year":"2015","unstructured":"Schepers E, Houthuys E, Dhondt A, De Meyer G, Neirynck N, Bernaert P, Van den Bergh R, Brouckaert P, Vanholder R, Glorieux G. Transcriptome analysis in patients with chronic kidney disease on hemodialysis disclosing a key role for CD16+CX3CR1+ monocytes. PLoS One. 2015;10(4):e121750.","journal-title":"PLoS One"},{"issue":"1","key":"866_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4049\/jimmunol.1001183","volume":"186","author":"K Eller","year":"2011","unstructured":"Eller K, Wolf D, Huber JM, Metz M, Mayer G, McKenzie AN, Maurer M, Rosenkranz AR, Wolf AM. IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol. 2011;186(1):83\u201391.","journal-title":"J Immunol"},{"issue":"5","key":"866_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ki.2011.178","volume":"80","author":"S Swaminathan","year":"2011","unstructured":"Swaminathan S, Shah SV. Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease. Kidney Int. 2011;80(5):453\u201363.","journal-title":"Kidney Int"},{"issue":"3","key":"866_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000348804","volume":"37","author":"B Kawar","year":"2013","unstructured":"Kawar B, Ellam T, Jackson C, Kiely DG. Pulmonary hypertension in renal disease: epidemiology, potential mechanisms and implications. Am J Nephrol. 2013;37(3):281\u201390.","journal-title":"Am J Nephrol"},{"issue":"5","key":"866_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.diabet.2008.08.001","volume":"34","author":"A Tiengo","year":"2008","unstructured":"Tiengo A, Fadini GP, Avogaro A. The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab. 2008;34(5):447\u201354.","journal-title":"Diabetes Metab"},{"issue":"2","key":"866_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/art.23303","volume":"58","author":"X Jais","year":"2008","unstructured":"Jais X, Launay D, Yaici A, Le Pavec J, Tcherakian C, Sitbon O, Simonneau G, Humbert M. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 2008;58(2):521\u201331.","journal-title":"Arthritis Rheum"},{"key":"866_CR28","doi-asserted-by":"publisher","first-page":"328435","DOI":"10.1155\/2015\/328435","volume":"2015","author":"KA Mensah","year":"2015","unstructured":"Mensah KA, Yadav R, Trow TK, Brunet CM, Fares WH. Lupus-associated pulmonary arterial hypertension: variable course and importance of prompt recognition. Case Rep Med. 2015;2015:328435.","journal-title":"Case Rep Med"},{"issue":"12","key":"866_CR29","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1164\/rccm.201412-2148OC","volume":"191","author":"E Wallace","year":"2015","unstructured":"Wallace E, Morrell NW, Yang XD, Long L, Stevens H, Nilsen M, Loughlin L, Mair KM, Baker AH, MacLean MR. A sex-specific MicroRNA-96\/5-Hydroxytryptamine 1B Axis influences development of pulmonary hypertension. Am J Respir Crit Care Med. 2015;191(12):1432\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"866_CR30","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1\u2013S266."},{"issue":"6","key":"866_CR31","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1159\/000146076","volume":"28","author":"S Abdelwhab","year":"2008","unstructured":"Abdelwhab S, Elshinnawy S. Pulmonary hypertension in chronic renal failure patients. Am J Nephrol. 2008;28(6):990\u20137.","journal-title":"Am J Nephrol"},{"issue":"2","key":"866_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/089686080902900214","volume":"29","author":"A Unal","year":"2009","unstructured":"Unal A, Sipahioglu M, Oguz F, Kaya M, Kucuk H, Tokgoz B, Buyukoglan H, Oymak O, Utas C. Pulmonary hypertension in peritoneal dialysis patients: prevalence and risk factors. Perit Dial Int. 2009;29(2):191\u20138.","journal-title":"Perit Dial Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-0866-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T19:47:22Z","timestamp":1604087242000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-0866-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-0866-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]},"assertion":[{"value":"10 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Research Committee at Tongji Hospital approved the study and agreed that informed consent was not necessary because of the observational nature (retrospective analysis) of this study. The information of all patients was anonymized and de-identified prior to analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"70"}}